VININDER KHUNKHUN: Open Payments
NPI 1306003504 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 8 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $111 |
| Alkermes, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: INVEGA, SPRAVATO, REXULTI, ARISTADA, CAPLYTA, VIVITROL.
Industry payments across LA — which companies pay providers there.
